Sanford Rose Associates – San Diego has placed Thomas McLain as president and chief executive officer of Vermillion, Inc. Mr. McLain recently served as both CEO and CFO of Claro Scientific, LLC, an innovative early stage diagnostic company.
Robin Toft, president and CEO of Sanford Rose Associates – San Diego, said: “Mr. McLain is a dynamic leader with 15 years experience as a president and CEO of both publicly traded and privately held venture growth companies focused on laboratory services, biopharmaceutical, biotechnology and healthcare services. He will be a valuable asset as Vermillion focuses on their global commercialization efforts.”
Sanford Rose Associates – San Diego provides specialized in building management teams for personalized medicine, molecular diagnostic and oncology companies.
Brian Binke, President and CEO of The Birmingham Group, Featured in Rigzone
FOR IMMEDIATE RELEASE: Brian Binke, President and CEO of The Birmingham Group – A member of the Sanford Rose Associates® network of offices, Featured in Rigzone, USA Oil, Gas Hiring Remains Disciplined By: Andreas [...]
Banister International Announces Next Phase of Growth
FOR IMMEDIATE RELEASE: Banister International – A member of the Sanford Rose Associates® network of offices, Announces Next Phase of Growth Plano, TX 2/23/2026 Banister International, a leading human capital advisory firm specializing in [...]
